All In MedTech

FDA Clearance Tracker · P040044

MATRIX VASCULAR CLOSURE SYSTEM (VSG)

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Aug 17, 2005 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Aug 17, 2005

Approved

Time to decision

286 days

Received Nov 4, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P040044
Device name
MATRIX VASCULAR CLOSURE SYSTEM (VSG)
Applicant location
Miami Lakes, FL
Received
Nov 4, 2004
Decided
Aug 17, 2005
Decision
Approved
Supplements
107 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MGB

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE MATRIX VSG SYSTEM, MODEL MX-100. THE DEVICE IS INDICATED FOR USE TO SEAL FEMORAL ARTERIAL ACCESS SITES WHILE REDUCING TIMES TO HEMOSTASIS AND AMBULATION IN PATIENTS WHO HAVE UNDERGONE DIAGNOSTIC OR INTERVENTIONAL ENDOVASCULAR PROCEDURES UTILIZING A 5F, 6F, OR 7F PROCEDURAL SHEATH.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MGB. The earliest in FDA's data is P920004, decided Sep 29, 1995.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Cordis US Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.